The weekly litigation news digest is live. Subscribe now

IP Verse

Immunogenic Composition

Patent No. EP3138916 (titled "Immunogenic Composition") was filed by Glaxosmithkline on May 25, 2012. The application was issued on Jun 19, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
VALNEVA AUSTRIAMar 16, 2020SCRIPT
VALNEVA AUSTRIAMar 16, 2020SCRIPT INTELLECTUAL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3138916

GLAXOSMITHKLINE
Application Number
EP16193340A
Filing Date
May 25, 2012
Status
Revoked
Oct 27, 2023
Publication Date
Jun 19, 2019
External Links
Slate, EP3138916B1, Google Patents